Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.
about
Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcriptPhosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivoThe serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcificationFetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonistCharacterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteriaMicrodialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular ProfilesDietary oil modifies the plasma proteome during aging in the ratAssociation between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scoresMarked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications.Proteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model.Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection.The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascadeAlpha2-HS glycoprotein: a protein in search of a function.Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients.The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot studyThe genetic polymorphism of alpha 2-HS glycoprotein: study by ultrathin-layer isoelectric focusing and immunoblot.Genetic polymorphism of alpha 2HS-glycoproteinEffects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis.The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI.Fetuin A concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerationsFatal calcific uraemic arteriolopathy (CUA): a case report and review of the literature.Proteomic Changes in the Plasma of Broiler Chickens with Femoral Head NecrosisShort-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patientsEvolution of inflammatory diseasesAlpha 2HS-glycoprotein in the serum and urine of patients with renal diseasesFetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules.Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome.Dynamic Analysis of Changes of Protein Levels and Selected Biochemical Indices in Rat Serum in the Course of Experimental PleurisyIn vivo protective effect of lipopolysaccharide against Pseudomonas aeruginosa exotoxin A in mice.Human plasma protein N-glycosylationKilled Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis.Genetic Considerations in Pediatric Chronic Kidney Disease.Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts.
P2860
Q24298954-B9C6B967-3115-401F-A2A5-DAF781A15E08Q24533356-23A3F97A-AF8C-4F40-90F1-6EA1D517B524Q24679476-80FABE0C-0E6C-49EA-9D50-6C1538CA61C8Q28281644-974802F0-EE19-43CE-81EA-340C2D68967EQ28475447-AEA27FD9-36C4-48EC-877F-CC579F029542Q28552772-CA25EA4E-3BF0-4D4B-A8AB-745B4DCE96C6Q28569420-E535EA06-6080-45AB-AB24-9BABE9C3AC69Q31035233-26928936-BEC3-4B34-9F93-57899D77242EQ31038421-D2C7F9A8-5753-41FA-9776-6CBD01CE9174Q33280499-040E19CF-00F5-4EE3-A006-C70A59479A0AQ33309151-E083F435-43EE-4BB7-960A-B6663E7D122CQ33632817-7FBE75D7-CEC4-4E19-9E05-7EB9508C04E9Q33748408-54496B8A-DEB2-4B38-A1A3-0A99807B0F02Q33916132-59D49B64-2868-46A2-9596-488C1C569DB1Q34014447-70C9768B-D8DE-4B92-8C33-CC9016E78BE5Q34059805-C89FA250-F4F2-47CE-B88F-0E538F424DCFQ34185823-7D609F35-116F-41BA-A62A-A4C5B74DE431Q34320256-6EB60B38-A432-42A3-B451-696A80AFB8B7Q34804253-E8186997-D2BD-4C6A-A5E5-407C05510905Q34927249-B4FD0903-C769-46C9-8344-88FDAB53B9CCQ35131450-3ACB1679-64A8-4C91-9AE4-5734F7817C61Q35200675-1B6D87C1-F1F0-4276-AC1B-AD85D714944BQ35200905-2709810E-B3A7-4121-8A50-02B4C4596ADCQ35331658-F7F6CB29-D88D-44B6-92F3-D21883B2036FQ35681974-F8DAEE7E-E56F-4847-A584-C00436B360ACQ35809242-1D19F8D7-EDAE-407F-8BA2-36C1796B9BBFQ35837896-2742D96C-BB40-42EF-BD55-A32E85238C3FQ35907454-BBFBD4F5-5AFD-49DF-B1A5-77BA140A2314Q36009051-8222866C-EED0-4287-A03E-472DB7358530Q36666977-414A3214-06E1-46FE-A718-25BFBFC8B9B8Q36697333-E7EFC84C-4686-49A2-848A-B4A94A39B25EQ36704431-8CEA67A8-BDAA-4760-982A-611302169549Q36735880-06D7A347-08B6-47C0-ADE6-EA02B6CCD109Q36793921-12D5533A-421C-4883-8708-A9FA741A1620Q36943041-1180D4A9-C3D3-4E06-9E3F-B69773ECCB06Q36963112-A9AA77C7-166F-41E0-97EB-5F8F2386991EQ36963945-A412424A-6729-4C87-A3EA-739D082130F4Q37032633-1BACC5F5-3436-4D19-9279-63CF6FBB8BB8Q37032679-4113F87F-EDFA-4925-83D4-049B077CC38CQ37170623-05FEB4A7-DA66-4041-A929-BD6752FEA045
P2860
Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum concentration of human a ...... negative acute-phase reactant.
@en
Serum concentration of human a ...... negative acute-phase reactant.
@nl
type
label
Serum concentration of human a ...... negative acute-phase reactant.
@en
Serum concentration of human a ...... negative acute-phase reactant.
@nl
prefLabel
Serum concentration of human a ...... negative acute-phase reactant.
@en
Serum concentration of human a ...... negative acute-phase reactant.
@nl
P2093
P2860
P356
P1476
Serum concentration of human a ...... negative acute-phase reactant.
@en
P2093
P2860
P304
P356
10.1172/JCI109551
P407
P577
1979-10-01T00:00:00Z